P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD

Detalles Bibliográficos
Autores principales: Piciocchi, Alfonso, Marconi, Giovanni, Cipriani, Marta, Messina, Monica, Guolo, Fabio, Minetto, Paola, Paoloni, Francesca, Cotugno, Francesca, DI Donato, Laura, Simonetti, Giorgia, Palmieri, Raffaele, Buccisano, Francesco, Fazi, Paola, Vignetti, Marco, M. Lemoni, Roberto, Venditti, Adriano, Martinelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429401/
http://dx.doi.org/10.1097/01.HS9.0000969000.00342.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429401/
http://dx.doi.org/10.1097/01.HS9.0000969000.00342.16

Ejemplares similares